These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30919301)

  • 1. Safety and Tolerability of Rapid Administration Undiluted Levetiracetam.
    Morgan O; Medenwald B
    Neurocrit Care; 2020 Feb; 32(1):131-134. PubMed ID: 30919301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid administration of undiluted intravenous levetiracetam.
    Haller JT; Bonnin S; Radosevich J
    Epilepsia; 2021 Aug; 62(8):1865-1870. PubMed ID: 34164804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid administration of undiluted loading doses of levetiracetam.
    Martinez S; Bonnin SS; Radosevich J; Haller JT
    Epilepsia; 2024 Mar; 65(3):615-619. PubMed ID: 38116700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the Safety and Tolerability of Rapid Administration of Undiluted Intravenous Levetiracetam in Pediatrics.
    Giannaccini C; Almendras C; Li I; DiNapoli M; Macnow T
    J Child Neurol; 2024 Jun; 39(7-8):241-245. PubMed ID: 38798130
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the Safety of Rapid Administration of Undiluted High-Dose Intravenous Levetiracetam.
    Kasturiarachi BM; Krishnan R; Alsbrook DL; Hudson B; Kelly H; Moran CE; Alsherbini K; Jones GM
    Neurohospitalist; 2022 Apr; 12(2):227-230. PubMed ID: 35419138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of intravenous undiluted levetiracetam in pediatrics: A retrospective cohort study.
    Singh R; Troelstrup D; Dahl N
    Epilepsia; 2024 Oct; ():. PubMed ID: 39425903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in toxic seizures.
    Lee T; Warrick BJ; Sarangarm P; Alunday RL; Bussmann S; Smolinske SC; Seifert SA
    Clin Toxicol (Phila); 2018 Mar; 56(3):175-181. PubMed ID: 28753046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous levetiracetam in clinical practice--Results from an independent registry.
    Lang N; Esser W; Evers S; Kellinghaus C; Nguento A; Schlegel U; Gaida B; Gburek-Augustat J; Altenmüller DM; Burghaus L; Hoffmann F; Fiedler B; Bast T; Rehfeld T; Happe S; Seitz RJ; Boor R; Stephani U
    Seizure; 2015 Jul; 29():109-13. PubMed ID: 26076852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam: safety and efficacy in neonatal seizures.
    Ramantani G; Ikonomidou C; Walter B; Rating D; Dinger J
    Eur J Paediatr Neurol; 2011 Jan; 15(1):1-7. PubMed ID: 21094062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
    Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
    Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution.
    Price L; Garrity L; Stiehl S
    Pharmacotherapy; 2024 Feb; 44(2):141-148. PubMed ID: 38050327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
    Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
    J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of levetiracetam for neonatal seizures in preterm infants.
    Han JY; Moon CJ; Youn YA; Sung IK; Lee IG
    BMC Pediatr; 2018 Apr; 18(1):131. PubMed ID: 29636029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of intravenous levetiracetam in status epilepticus: A meta-analysis and systematic review.
    Chu SS; Wang HJ; Zhu LN; Xu D; Wang XP; Liu L
    Seizure; 2020 Jan; 74():49-55. PubMed ID: 31830677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
    Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
    Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses.
    Reinert JP; Maktabi L; Branam D; Snyder M
    Expert Rev Neurother; 2022 Mar; 22(3):231-236. PubMed ID: 35240911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
    Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
    Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
    Szaflarski JP; Sangha KS; Lindsell CJ; Shutter LA
    Neurocrit Care; 2010 Apr; 12(2):165-72. PubMed ID: 19898966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.